Indonesia
· Delayed Price · Currency is IDR PT Diagnos Laboratorium Utama Tbk Company Description
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia.
The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want to have a child, oncology tests, drug sensitivity, DNAandMe, and others.
It also offers homecare health services for hemoglobin, ferritin, retilulosit, hematologi rutin, SARS-COV-2 omicron screening molecular test, and PCR SARS-COV-2 H+1 B2C; and SARS-CoV-2 screening services.
The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.
| Country | Indonesia |
| Founded | 2007 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 96 |
| CEO | Mesha Sini |
Contact Details
Address: Gedung Graha Anam Lantai 2 Jakarta Pusat, 10350 Indonesia | |
| Phone | 62 21 3193 1833 |
| Website | diagnos.co.id |
Stock Details
| Ticker Symbol | DGNS |
| Exchange | Indonesia Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | IDR |
| ISIN Number | ID1000158702 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Engineer Mesha Rizal Sini | President Director |
| Martinus Eliatulo Zega | GM of Sales and Independent Commissioner |
| Fergus Richard | MD and Director |
| Maurina Dwiyanthi | Head of Internal Audit Unit and Manager of SPI |
| Fanfan Riksani | Corporate Secretary |